Medical Advisory Board

Bioasis has assembled a team of exceptional oncology key opinion leaders. They will guide the clinical strategy and design of the xB3 TM -001 clinical program for the treatment of HER2+ breast cancer and brain metastases. Members of the Bioasis Medical Oncology Advisory Board are proven leaders in the field who will strengthen Bioasis’ oncology development. Their scientific insights will help Bioasis achieve its goal to revolutionize the treatment of brain metastases.